Quinoline sulfonamides and their therapeutic use
US5834485A · kind A · utility
107Cited by
2References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 1997 |
| Grant date | Nov 10, 1998 |
| Priority date | — |
| Expiry date | May 20, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention pertains to quinolinesulfonamides. The subject compounds can be used to treat disease states, such as those that are associated with proteins that mediate cellular activity, for example, by inhibiting phosphodiesterase IV (PDE IV) or tumor necrosis factor (TNF). The invention also pertains to methods of treating disease states, including those states capable of being modulated by inhibition of PDE IV or TNF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.